The theoretical reasons for the likely efficacy of passive immunization, the urgent need felt by clinicians worldwide for effective treatment options for COVID-19, and the promising results offered mainly by retrospective clinical studies must be balanced against the lack of efficacy in the RCTs of CP and hyperimmune globulin therapy in severe influenza and COVID-19. Here, CP is linked to influenza.